塑料支架与自膨式金属支架在恶性胆道梗阻姑息治疗中的比较:一系列荟萃分析
该系统检索1980年1月至2015年9月多个数据库的随机对照试验,比较自膨式金属支架(SEMS)与塑料支架在恶性胆道梗阻姑息治疗中的效果。共纳入20项RCT、1713例患者,SEMS在支架通畅时间、晚期并发症、脓毒症或胆管炎、污泥堵塞及再干预次数方面均优于塑料支架,但总体生存率和30天死亡率无差异;特定亚组中SEMS显示生存获益。
要点
- SEMS较塑料支架延长支架通畅时间加权均数差4.45个月(95%CI 0.31,8.59;GRADE=中等)。
- SEMS降低晚期并发症(OR=0.43)、脓毒症或胆管炎(OR=0.53)、污泥堵塞(OR=0.11)及再干预次数(WMD=-0.83)。
- 总体生存率(WMD=0.67个月,95%CI -0.66,1.99)和30天死亡率(OR=0.80,95%CI 0.52,1.24)无显著差异。
核心结论
- 在注意源数据存在偏倚风险的前提下,与塑料支架相比,SEMS用于恶性胆道梗阻姑息治疗可获得更长的支架通畅时间、更低的并发症发生率和更少的再干预次数,并在特定亚组患者中显示生存获益。
研究设计与样本
- 系统检索MEDLINE、EMBASE、Scopus、CENTRAL和ISI Web of knowledge数据库1980年1月至2015年9月的随机对照试验(RCT),比较SEMS与塑料支架在恶性胆道梗阻姑息治疗中的效果,共纳入20项RCT、1713例患者。
主要发现
- 支架通畅时间(4项研究)加权均数差(WMD)为4.45个月(95%CI 0.31,8.59;GRADE=中等),有利于SEMS。
- 总体生存率(5项研究)WMD=0.67个月(95%CI -0.66,1.99;GRADE=中等),30天死亡率(8项研究)OR=0.80(95%CI 0.52,1.24;GRADE=中等),均无显著差异。
- 6个月无症状生存率(4项研究)OR=5.96(95%CI 1.71,20.81;GRADE=中等),有利于SEMS。
- SEMS组晚期并发症(11项研究)OR=0.43(95%CI 0.26,0.71;GRADE=中等)、脓毒症或胆管炎(14项研究)OR=0.53(95%CI 0.37,0.77;GRADE=高)、污泥堵塞(8项研究)OR=0.11(95%CI 0.07,0.17;GRADE=中等)及平均再干预次数(8项研究)WMD=-0.83次(95%CI -1.64,-0.02;GRADE=中等)均低于塑料支架。
- 无先前引流尝试者(2项研究)SEMS通畅时间WMD=7.70个月(95%CI 7.14,8.25;GRADE=高);未覆膜SEMS(3项研究)生存获益WMD=1.31个月(95%CI 0.30,2.32;GRADE=高),部分或完全覆膜SEMS(2项研究)WMD=-0.66个月(95%CI -1.02,-0.30;GRADE=高);术前或术后使用抗生素(2项研究)WMD=1.49个月(95%CI 0.27,2.70;GRADE=高)及行括约肌切开(2项研究)WMD=1.63个月(95%CI 0.42,2.84;GRADE=高)时SEMS显示生存获益。
关键数值与推荐
- SEMS较塑料支架延长支架通畅时间WMD=4.45个月(95%CI 0.31,8.59;GRADE=中等)。
- SEMS较塑料支架降低晚期并发症OR=0.43(95%CI 0.26,0.71;GRADE=中等)、脓毒症或胆管炎OR=0.53(95%CI 0.37,0.77;GRADE=高)、污泥堵塞OR=0.11(95%CI 0.07,0.17;GRADE=中等)及再干预次数WMD=-0.83次(95%CI -1.64,-0.02;GRADE=中等)。
- 总体生存率WMD=0.67个月(95%CI -0.66,1.99;GRADE=中等)和30天死亡率OR=0.80(95%CI 0.52,1.24;GRADE=中等)两组间无显著差异。
- 6个月无症状生存率OR=5.96(95%CI 1.71,20.81;GRADE=中等),有利于SEMS。
临床怎么用
- 作者结论认为,在注意源数据偏倚风险的前提下,SEMS较塑料支架用于恶性胆道梗阻姑息治疗可获得更长的支架通畅时间、更低的并发症发生率和更少的再干预次数,并在特定亚组中显示生存获益。
局限性
- 原文指出源数据存在偏倚风险(risk of bias in source data)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Self-expandable metal stents (SEMS) are thought to have an advantage over plastic stents in achieving biliary drainage. METHODS: We performed a systematic search of MEDLINE, EMBASE, Scopus, CENTRAL, and ISI Web of knowledge databases, from January 1980 to September 2015, for randomized-controlled trials (RCTs) comparing SEMS vs. plastic stents in the palliation of malignant biliary obstruction. Primary outcomes were durations of stent patency, patient survival, and 30-day mortality. Numerous secondary outcomes were assessed, and extensive sensitivity and subgroup analyses were performed. RESULTS: In all, 20 RCTs totaling 1,713 patients yielded a weighted mean difference (WMD) in time to stent patency (4 studies) of 4.45 months (95% confidence interval (CI), 0.31, 8.59; GRADE=moderate) favoring SEMS. There were no differences in overall patient survival (5 studies) WMD=0.67 months (95% CI, -0.66, 1.99; GRADE=moderate), or 30-day mortality (8 studies) odds ratio (OR)=0.80 (95% CI, 0.52, 1.24; GRADE=moderate) but there was a higher symptom-free survival at 6 months (4 studies) OR=5.96 (95% CI, 1.71, 20.81; GRADE=moderate). SEMS use resulted in lower rates of late complications (11 studies) OR=0.43 (95% CI, 0.26, 0.71; GRADE=moderate), sepsis or cholangitis (14 studies) OR=0.53 (95% CI, 0.37, 0.77; GRADE=high), blocking from sludge (8 studies) OR=0.11(95% CI, 0.07, 0.17; GRADE=moderate), and mean number of re-interventions (8 studies) WMD=-0.83 interventions (95% CI, -1.64, -0.02; GRADE=moderate). There was a longer patency of SEMS for those without a prior drainage attempt (2 studies) WMD 7.70 months (95% CI, 7.14, 8.25; GRADE=high). Although a survival advantage was found when an uncovered SEMS was used (3 studies) WMD 1.31 months (95% CI, 0.30, 2.32; GRADE=high), but not partially or fully covered SEMS (2 studies) WMD -0.66 months (95% CI, -1.02, -0.30; GRADE=high) vs. plastic stents, and for SEMS in the setting of pre- or post-procedural antibiotic administration (2 studies) WMD 1.49 months (95% CI, 0.27, 2.70; GRADE=high), and performance of a sphincterotomy (2 studies) WMD 1.63 months (95% CI, 0.42, 2.84; GRADE=high). CONCLUSIONS: Keeping in mind the noted risk of bias in source data, the use of SEMS compared with plastic stents, in the palliation of patients with malignant biliary obstruction results in longer stent patency, lower complications rates, and fewer re-interventions, whereas exhibiting survival benefits in selected subgroups of patients.
引用
- Almadi MA, Barkun A, Martel M, et al. Plastic vs. Self-Expandable Metal Stents for Palliation in Malignant Biliary Obstruction: A Series of Meta-Analyses. Am J Gastroenterol. 2016. PMID: 27845340. doi:10.1038/ajg.2016.512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。